Product Information
ALCLOMETASONE DIPRO 0.05% CRM is a generic product labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., priced at $1.2482 per GM under NDC 00168026360. Its NADAC has been published 652 times since Nov 28, 2013.
FDA first approved this application on Jul 12, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
NDC
00168026360
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
5/20/2026
Active Ingredients
ALCLOMETASONE DIPROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA076973FDA Approved
7/12/2005
TE Code
AB
On Market Since
7/12/2005
Pharmacological Classes
Price Statistics
The NADAC for ALCLOMETASONE DIPRO 0.05% CRM has been published 652 times since Nov 28, 2013, and over the history we have for it it has risen 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2482 per GM |
|---|---|
| All-time high | $1.3764 (May 14, 2014) |
| All-time low | $0.4284 (Jul 17, 2024) |
| 52-week high | $1.2482 |
| 52-week low | $0.5721 |
| Median price | $0.9688 |
| Average price | $0.9348 |
| Largest weekly change | +110.5% (Feb 18, 2026) |
| Weeks tracked | 652 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+3.6%
1Y
+118.2%
3Y
+94.2%
5Y
+9.3%
All
+4.8%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALCLOMETASONE DIPRO 0.05% CRM?
The current National Average Drug Acquisition Cost (NADAC) for ALCLOMETASONE DIPRO 0.05% CRM, manufactured by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., is $1.2482 per GM (NDC 00168026360), effective May 20, 2026.
How has the price of ALCLOMETASONE DIPRO 0.05% CRM changed over time?
Over the history we have for it, the NADAC for ALCLOMETASONE DIPRO 0.05% CRM has risen 4.8%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALCLOMETASONE DIPRO 0.05% CRM?
Since Nov 28, 2013, the NADAC for ALCLOMETASONE DIPRO 0.05% CRM has ranged from a low of $0.4284 (Jul 17, 2024) to a high of $1.3764 (May 14, 2014), with a median of $0.9688 per GM.
Are there cheaper alternatives to ALCLOMETASONE DIPRO 0.05% CRM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALCLOMETASONE DIPRO 0.05% CRM, is $0.5518 per GM — about 56% below ALCLOMETASONE DIPRO 0.05% CRM.
Who manufactures ALCLOMETASONE DIPRO 0.05% CRM?
ALCLOMETASONE DIPRO 0.05% CRM (NDC 00168026360) is labeled by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc., and CMS classifies it as a generic product.